Galil Medical
Date | Investors | Amount | Round |
---|---|---|---|
$52.0m | Late VC | ||
$110m Valuation: $110m | Acquisition | ||
Total Funding | $52.0m |
Related Content
Recent News about Galil Medical
EditGalil Medical specializes in cryoablation technology, offering minimally invasive solutions for cancer treatment. The company serves healthcare providers and medical institutions, focusing on the oncology market. Its business model revolves around the development, manufacturing, and distribution of advanced cryoablation systems. Revenue is generated through the sale of these systems and related consumables. Galil Medical's technology is designed to improve patient outcomes by precisely targeting and destroying cancerous tissues while minimizing damage to surrounding healthy tissues. The company operates globally, with a strong presence in North America and Europe.
Keywords: cryoablation, cancer treatment, minimally invasive, oncology, healthcare providers, medical institutions, precision technology, patient outcomes, global presence, advanced systems.